RECRUITING Not applicable ClinicalTrials.gov

Efficacy of a New Infant Formula Composition on Gut Health in Infants

Sponsor: FrieslandCampina • ClinicalTrials.gov ID: NCT07242508

Registry updated: 2026-09-03

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Description

The aim of this study is to investigate potential health benefits of the experimental formula. The main objective is whether the experimental formula elevates the relative abundance of Bifidobacterium in stool samples after 10 weeks, as compared a standard formula, aka control formula. In addition other markers of gut health, such as stool characteristics, and gut health symptoms will be monitored

Interventions

Infant Formula (Other)
ad-libitum consumption of infant formula
Infant Formula with bioactive ingredients (Other)
ad-libitum consumption

Eligibility criteria

Inclusion Criteria: * Healthy, full term, infants with a birth weight between 2500-4500 grams * Parents independently from study decided to not breastfeed their infant * Parents agree to feed the assigned study formula as the infant's sole source of nutrition for the duration of the study * have read and voluntarily signed an informed consent form * parents are capable of completing study procedures required by the protocol Exclusion Criteria: * suffering from any anatomic and/or physiologic condition that would interfere with normal growth, development or feeding * are required to take medications or supplements known to influence growth and development * have a maternal history with known adverse effects on the fetus and/or the newborn infant * have previous or current antibiotics use (antibiotics administered during delivery are permitted) * have received or are planning to receive probiotics, prebiotics, or nutritional supplements prior to and throughout the trial (excluding vitamin D and vitamin K supplementation) * personal history of or parents/siblings diagnosed with cow's milk protein allergy or lactose intolerance * multiple birth * participation in another trial

Conditions

Healthy Infants

Locations

Second SAGBAL Sheinovo AD — Sofia, Bulgaria

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record

Accelerate Your Clinical Trial Recruitment